Table 4.
Clinical outcomes including best overall response, progression free survival, and overall survival
Cohort | All | |||||
---|---|---|---|---|---|---|
Level − 1 | Level 1 | |||||
N | % | N | % | N | % | |
All | 4 | 100.0 | 7 | 100.0 | 11 | 100.0 |
Best overall response | ||||||
Inevaluable | 0 | 0.0 | 1 | 14.3 | 1 | 9.1 |
Progressive disease | 4 | 100.0 | 4 | 57.1 | 8 | 72.7 |
Stable disease | 0 | 0.0 | 2 | 28.6 | 2 | 18.2 |
Median OS (95% CI) in months | 2.76 | 1.25–4.21 | 7.23 | 2.04–10.0 | 4.21 | 2.04–9.46 |
Median PFS (95% CI) in months | 1.71 | 0.92–1.84 | 1.91 | 0.95–9.46 | 1.84 | 0.95–4.14 |